Who owns Cara Therapeutics?
- Ticker: CARA
- CUSIP Number: 140755109
Tip: Access positions for across all investors
Analyze quarterly positions in Cara Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cara Therapeutics stock
Who bought or sold Cara Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.3M | $581k | -9% | Jun 2024 |
|
| Chescapmanager | 1.7M | $524k | 0% | Sep 2024 |
|
| Farallon Capital Management | 1.6M | $402k | 0% | Jun 2024 |
|
| Disciplined Growth Investors | 1.1M | $343k | -42% | Sep 2024 |
|
| Renaissance Technologies | 1.1M | $342k | 4% | Sep 2024 |
|
| Two Sigma Advisers | 862k | $222k | 31% | Jun 2024 |
|
| BlackRock | 745k | $192k | -78% | Jun 2024 |
|
| BlackRock | 743k | $229k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 583k | $179k | -46% | Sep 2024 |
|
| Geode Capital Management | 452k | $139k | -4% | Sep 2024 |
|
| Stifel Financial | 443k | $114k | -40% | Jun 2024 |
|
| Goldman Sachs Group | 390k | $101k | 655% | Jun 2024 |
|
| Bank of America Corporation | 327k | $101k | -31% | Sep 2024 |
|
| Two Sigma Investments | 254k | $66k | -9% | Jun 2024 |
|
| State Street Corporation | 181k | $47k | -82% | Jun 2024 |
|
| LPL Financial | 149k | $46k | -1% | Sep 2024 |
|
| Susquehanna International | 128k | $39k | -31% | Sep 2024 |
|
| Northern Trust | 85k | $26k | -78% | Sep 2024 |
|
| Virtu Financial | 76k | $20k | 100% | Jun 2024 |
|
| Morgan Stanley | 69k | $18k | -35% | Jun 2024 |
|
| Qube Research & Technologies | 67k | $17k | 100% | Jun 2024 |
|
| Penserra Capital Management | 64k | $19k | -7% | Sep 2024 |
|
| National Asset Management | 62k | $16k | 11% | Jun 2024 |
|
| Jane Street | 54k | $17k | -86% | Sep 2024 |
|
| Verition Fund Management | 50k | $13k | -89% | Jun 2024 |
|
| Acadian Asset Management | 46k | $13k | -83% | Sep 2024 |
|
| Ferguson Wellman Capital Management | 35k | $11k | 100% | Sep 2024 |
|
| Citigroup | 23k | $7.1k | -22% | Sep 2024 |
|
| Tower Research Capital | 23k | $5.8k | 97% | Jun 2024 |
|
| Rathbones Brothers | 20k | $5.2k | 0% | Jun 2024 |
|
| Corsair Capital Management | 20k | $6.1k | 100% | Sep 2024 |
|
| AQR Capital Management | 14k | $4.3k | -58% | Sep 2024 |
|
| Assenagon Asset Management | 14k | $4.2k | -5% | Sep 2024 |
|
| Russell Investments | 13k | $3.4k | 100% | Jun 2024 |
|
| Camden Capital | 13k | $3.9k | 100% | Sep 2024 |
|
| Gail Mannix | 12k | $8.7k | -80% | Sep 2024 |
|
| Franklin Resources | 11k | $2.9k | 0% | Sep 2024 |
|
| Roberta J. Maue | 11k | $3.5k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 9.5k | $2.9k | -25% | Sep 2024 |
|
| SRS Capital Advisors | 7.6k | $2.3k | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 5.3k | $1.6k | -93% | Sep 2024 |
|
| Cypress Capital Management | 5.0k | $1.5k | 0% | Sep 2024 |
|
| Federated Investors | 4.8k | $1.5k | -61% | Sep 2024 |
|
| LRI Investments | 3.0k | $983.100000 | 50% | Sep 2024 |
|
| Macquarie Group | 2.4k | $614.040000 | 100% | Jun 2024 |
|
| Northwestern Mutual Wealth Management Company | 2.0k | $621.958000 | 100% | Sep 2024 |
|
| Goss Wealth Management | 1.2k | $301.036000 | 0% | Jun 2024 |
|
| Wells Fargo & Company | 1.1k | $334.053600 | -11% | Sep 2024 |
|
| Group One Trading | 849.00 | $260.982600 | -98% | Sep 2024 |
|
| WR Wealth Planners | 746.00 | $229.991800 | 100% | Sep 2024 |
|
| Hanson McClain Advisors | 719.00 | $222.027200 | 0% | Sep 2024 |
|
| CWM | 708.00 | $0 | -27% | Sep 2024 |
|
| Harbour Investments | 525.00 | $162.015000 | 0% | Sep 2024 |
|
| Baldwin Brothers | 500.00 | $154.000000 | -86% | Sep 2024 |
|
| Benjamin F. Edwards & Company | 500.00 | $0 | 0% | Jun 2024 |
|
| Royal Bank of Canada | 449.00 | $0 | -90% | Sep 2024 |
|
| Simplex Trading | 307.00 | $0 | -92% | Sep 2024 |
|
| FinTrust Capital Advisors | 260.00 | $80.990000 | 0% | Sep 2024 |
|
| Creative Financial Designs | 220.00 | $68.002000 | 0% | Sep 2024 |
|
| Steward Partners Investment Advisory | 150.00 | $39.000000 | 0% | Jun 2024 |
|
| Sound Income Strategies | 100.00 | $31.000000 | 0% | Sep 2024 |
|
| Proequities | 100.00 | $30k | 0% | Sep 2024 |
|
| Front Row Advisors | 80.00 | $25.000000 | 0% | Sep 2024 |
|
| Cornerstone Planning Group | 40.00 | $11.000000 | 0% | Sep 2024 |
|
| Brian McDonald | 40.00 | $12.000000 | 0% | Sep 2024 |
|
| Us Bancorp | 35.00 | $11.000500 | 0% | Sep 2024 |
|
| Parallel Advisors | 4.00 | $1.000000 | 0% | Sep 2024 |
|
| DHJJ Financial Advisors | 2.00 | $1.000000 | 0% | Sep 2024 |
|
Who sold out of Cara Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 587k | $151k |
| Y-Intercept | Jun 2024 | 415k | $107k |
| Charles Schwab Investment Management | Jun 2024 | 223k | $58k |
| Hrt Financial | Jun 2024 | 164k | $42k |
| Nuveen Asset Management | Mar 2024 | 114k | $104k |
| Centiva Capital | Jun 2024 | 97k | $25k |
| Alliancebernstein | Mar 2024 | 87k | $80k |
| Sunrise Partners Limited Partnership | Jun 2024 | 55k | $14k |
| Citadel Advisors | Jun 2024 | 51k | $13k |
| Rhumbline Advisers | Jun 2024 | 31k | $7.9k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 24k | $6.3k |
| Barclays | Jun 2024 | 17k | $4.0k |
| Wealth Effects | Jun 2024 | 14k | $3.5k |
| Baader Bank | Jun 2024 | 13k | $2.7k |
| Manufacturers Life Insurance Company | Mar 2024 | 12k | $11k |
| Two Sigma Securities | Mar 2024 | 11k | $10k |
| Quantbot Technologies | Mar 2024 | 8.7k | $7.9k |
| New York State Common Retirement Fund | Jun 2024 | 405.00 | $0 |
| Truvestments Capital | Mar 2024 | 176.00 | $160.001600 |
| Abich Financial Wealth Management | Jun 2024 | 140.00 | $35.994000 |